Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Exact Sciences Cor
(NQ:
EXAS
)
58.86
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
16
Open
58.86
Bid (Size)
57.00 (5)
Ask (Size)
58.79 (1)
Prev. Close
58.86
Today's Range
58.86 - 58.86
52wk Range
56.05 - 100.77
Shares Outstanding
171,948,769
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
March 13, 2024
From
Exact Sciences Corp.
Via
Business Wire
Cathie Wood Darling Exact Sciences Could Pop After Its Next-Gen Product Outperforms
March 13, 2024
Exact Sciences is hoping to launch an next-generation version of Cologuard in 2025.
Via
Investor's Business Daily
Performance
YTD
-20.21%
-20.21%
1 Month
-6.18%
-6.18%
3 Month
-8.89%
-8.89%
6 Month
-21.83%
-21.83%
1 Year
-7.22%
-7.22%
More News
Read More
2 Beaten-Down Cathie Wood Stocks With Massive Potential
March 11, 2024
Via
The Motley Fool
5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024
March 09, 2024
Via
Talk Markets
Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer
March 07, 2024
From
Exact Sciences Corp.
Via
Business Wire
Earnings Scheduled For February 21, 2024
February 21, 2024
Via
Benzinga
Earnings Preview For Exact Sciences
February 20, 2024
Via
Benzinga
Cathie Wood Is Selling This Stock: Should You?
February 07, 2024
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
March 06, 2024
Via
Benzinga
The Top 3 Healthcare Stocks to Buy on Weakness in 2024
March 04, 2024
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
March 04, 2024
Via
Benzinga
7 Stable Stocks to Buy for 100% Returns by 2025
March 04, 2024
Via
InvestorPlace
Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices
March 03, 2024
Via
InvestorPlace
3 Hot Stocks Bought by Members of Congress: Follow the Money
March 01, 2024
Via
MarketBeat
Exact Sciences to Participate in March Investor Conference
February 26, 2024
From
Exact Sciences Corp.
Via
Business Wire
Nasdaq, S&P 500 Futures Jump As Nvidia Surge Raises 'FOMO' Rally Hopes: Analyst Tells Why Jobs Data Holds Key For Momentum
February 22, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Exact Sciences (EXAS) Q4 2023 Earnings Call Transcript
February 22, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Exact Sciences Announces Fourth Quarter 2023 Results
February 21, 2024
From
Exact Sciences Corp.
Via
Business Wire
Wall Street Waits With Bated Breath For Nvidia Earnings After Tech Selloff, Fed Minutes Eyed: Analyst Flags This As Biggest Risk For Market
February 21, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge
February 02, 2024
Via
News Direct
Topics
Death
Exposures
Death
2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge
February 01, 2024
Via
Benzinga
Topics
Death
Exposures
Death
Exact Sciences Schedules Fourth Quarter 2023 Earnings Call
February 01, 2024
From
Exact Sciences Corp.
Via
Business Wire
3 Stocks to Buy for the Age of Personalized Medicine
January 28, 2024
Via
InvestorPlace
2 Cathie Wood Growth Stocks to Buy and Hold for the Long Haul
January 22, 2024
Via
The Motley Fool
The Top 3 Stocks in the High-Potential ‘Cancer Testing’ Market
January 18, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.